idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instanz:
Teilen: 
05.07.2006 11:37

Immunological Approaches to Cancer Treatment - New Transregional Collaborative Research Center

Barbara Bachtler Kommunikation
Max-Delbrück-Centrum für Molekulare Medizin (MDC) Berlin-Buch

    A new transregional research collaboration to explore new approaches to cancer treatment with the aid of the immune system was now established in Berlin and Munich. The project "Principles and Applications of Adoptive T Cell Therapy" is a long-term multicenter research undertaking involving the Charité - Universitätsmedizin Berlin (Free University Berlin und Humboldt University), the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, the GSF - National Research Center for Environment and Health in Munich as well as the Technical University and the Ludwig Maximilian University (both Munich) and the German Rheuma Research Center, Berlin. The German Research Foundation (DFG) is allocating six million euros to this Transregional Collaborative Research Center project (Transregio or SFB/TR for short), initially for the next four years.

    The aim of the research is to develop methods to strengthen the body's own immune system to fight cancer diseases which can no longer be treated using chemotherapy, radiotherapy, or surgery. This form of tumor treatment, which has received very little attention from German researchers to date, is known as adoptive T cell therapy. In this method, T cells which specifically target cancer cells or viral-infected cells are generated outside the body in vitro and then administered to the patient by infusion.

    Until now, there has been very little clinical experience with this form of treatment because it is very cost-intensive and difficult to administer. "Our aim is thus to develop methods of making adoptive T cell therapy easier to implement and more effective," explains Professor Thomas Blankenstein (Charité/MDC), spokesperson of this research undertaking. "The goal is a therapy for hitherto incurable cancer diseases and virus infections."

    "Our aim is to integrate basic research in immunology and clinical research," stresses Professor Dolores Schendel of the GSF - National Research Center for Environment and Health, who is the deputy spokesperson for this new research project. "We plan to develop experimental systems to generate highly effective T cells." Simultaneously, the project aims to identify the best conditions for attaining maximum effectiveness, particularly in terms of T cell longevity and functioning. The long-term objective is to produce sufficient quantities of human T cells that can be modified to suit individual patients and then be used clinically. A further deputy spokesperson is Professor Wolfgang Uckert, Institute for Biology, HU Berlin/MDC.

    Transregios are special collaborative research undertakings funded by the German Research Foundation in which universities and research centers from different regions carry out long-term multicenter research projects.

    Further information:

    Barbara Bachtler
    Max Delbrück Center for Molecular Medicine(MDC) Berlin-Buch
    Press and Public Affairs
    Robert-Rössle-Str. 10; D-13125 Berlin
    Germany
    Phone: +49/30/9406-38 96
    Fax.: +49/30/9406-38 33
    e-mail: bachtler@mdc-berlin.de
    http://www.mdc-berlin.de/englisch/about_the_mdc/public_relations/e_index.htm

    Heinz-Jörg Haury
    GSF - National Research Center
    for Environment and Health
    Press and Public Relations
    Ingolstädter Landstr. 1
    85764 Neuherberg/Oberschleißheim
    Germany
    Phone: +49/89/ 31 87 - 24 60
    Fax: +49/89/ 31 87 - 33 24
    e-mail: oea@gsf.de
    http://www.gsf.de


    Bilder

    Professor Thomas Blankenstein (Charité/MDC) - spokesperson for the Transregio collaborative research center project
    Professor Thomas Blankenstein (Charité/MDC) - spokesperson for the Transregio collaborative research ...
    Photo: David Ausserhofer/Copyright: MDC
    None

    Professor Dolores Schendel of the Institute of Molecular Immunology and Immune Monitoring Platform of the GSF - deputy spokesperson of the Transregio collaborative research center project
    Professor Dolores Schendel of the Institute of Molecular Immunology and Immune Monitoring Platform o ...
    Photo: Ulla Baumgart/Copyright: GSF
    None


    Merkmale dieser Pressemitteilung:
    Biologie, Chemie, Ernährung / Gesundheit / Pflege, Informationstechnik, Medizin
    überregional
    Forschungsprojekte
    Englisch


     

    Professor Thomas Blankenstein (Charité/MDC) - spokesperson for the Transregio collaborative research center project


    Zum Download

    x

    Professor Dolores Schendel of the Institute of Molecular Immunology and Immune Monitoring Platform of the GSF - deputy spokesperson of the Transregio collaborative research center project


    Zum Download

    x

    Hilfe

    Die Suche / Erweiterte Suche im idw-Archiv
    Verknüpfungen

    Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.

    Klammern

    Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).

    Wortgruppen

    Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.

    Auswahlkriterien

    Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).

    Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).